LCTX
Price
$0.59
Change
+$0.02 (+3.51%)
Updated
Jan 17 closing price
Capitalization
129.47M
46 days until earnings call
VTGN
Price
$2.92
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
81.3M
Ad is loading...

LCTX vs VTGN

Header iconLCTX vs VTGN Comparison
Open Charts LCTX vs VTGNBanner chart's image
Lineage Cell Therapeutics
Price$0.59
Change+$0.02 (+3.51%)
Volume$715.24K
Capitalization129.47M
VistaGen Therapeutics
Price$2.92
Change-$0.00 (-0.00%)
Volume$108.72K
Capitalization81.3M
LCTX vs VTGN Comparison Chart
Loading...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LCTX vs. VTGN commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Hold and VTGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (LCTX: $0.59 vs. VTGN: $2.92)
Brand notoriety: LCTX and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 24% vs. VTGN: 36%
Market capitalization -- LCTX: $129.47M vs. VTGN: $81.3M
LCTX [@Biotechnology] is valued at $129.47M. VTGN’s [@Biotechnology] market capitalization is $81.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $352.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both LCTX and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 2 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).

  • LCTX’s TA Score: 2 bullish, 4 bearish.
  • VTGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than LCTX.

Price Growth

LCTX (@Biotechnology) experienced а +1.28% price change this week, while VTGN (@Biotechnology) price change was -1.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

LCTX is expected to report earnings on May 08, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($129M) has a higher market cap than VTGN($81.3M). LCTX YTD gains are higher at: 16.896 vs. VTGN (-1.017). LCTX has higher annual earnings (EBITDA): -22.1M vs. VTGN (-45M). VTGN has more cash in the bank: 97.6M vs. LCTX (32.7M). VTGN has less debt than LCTX: VTGN (1.79M) vs LCTX (2.75M). LCTX has higher revenues than VTGN: LCTX (8.72M) vs VTGN (876K).
LCTXVTGNLCTX / VTGN
Capitalization129M81.3M159%
EBITDA-22.1M-45M49%
Gain YTD16.896-1.017-1,661%
P/E RatioN/AN/A-
Revenue8.72M876K995%
Total Cash32.7M97.6M34%
Total Debt2.75M1.79M153%
FUNDAMENTALS RATINGS
LCTX vs VTGN: Fundamental Ratings
LCTX
VTGN
OUTLOOK RATING
1..100
2373
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
6455
P/E GROWTH RATING
1..100
67100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (41) in the null industry is in the same range as VTGN (43) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VTGN’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as VTGN (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VTGN’s over the last 12 months.

LCTX's SMR Rating (96) in the null industry is in the same range as VTGN (98) in the Biotechnology industry. This means that LCTX’s stock grew similarly to VTGN’s over the last 12 months.

VTGN's Price Growth Rating (55) in the Biotechnology industry is in the same range as LCTX (64) in the null industry. This means that VTGN’s stock grew similarly to LCTX’s over the last 12 months.

LCTX's P/E Growth Rating (67) in the null industry is somewhat better than the same rating for VTGN (100) in the Biotechnology industry. This means that LCTX’s stock grew somewhat faster than VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXVTGN
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
84%
Momentum
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 20 days ago
83%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Ad is loading...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
BTC.X104408.070000-53.968750
-0.05%
Bitcoin cryptocurrency
GME27.51-0.21
-0.76%
GameStop Corp

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with GBIO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+2.80%
GBIO - LCTX
36%
Loosely correlated
+0.18%
APTO - LCTX
34%
Loosely correlated
+3.33%
MGTX - LCTX
34%
Loosely correlated
+5.56%
VTGN - LCTX
32%
Poorly correlated
N/A
ATAI - LCTX
30%
Poorly correlated
+5.04%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ATAI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
N/A
ATAI - VTGN
42%
Loosely correlated
+5.04%
MGTX - VTGN
38%
Loosely correlated
+5.56%
ZYME - VTGN
38%
Loosely correlated
-0.79%
ABCL - VTGN
38%
Loosely correlated
+1.02%
SRRK - VTGN
38%
Loosely correlated
-1.75%
More